Pharmacy Program

Delivering Integrated Care and Cost Management

The IHTC works collaboratively with payors to optimize care. We ensure that the patients and families we serve have access to care and therapies, thereby helping to contain costs and reduce both bleeding events and utilization of resources.

The IHTC Pharmacy’s ability to purchase clotting factor through the Public Health Service 340B discount program and our overall pricing structure benefit payors and patients by dispensing clotting factor at significantly reduced prices.

Sickle Cell Disease Resources

The IHTC is involved a variety of research studies to better understand the complications of sickle cell disease. It is our hope that this research will allow the medical community at large to develop treatments to prevent or minimize complications, prolong and improve the quality of life for those with sickle cell disease.

Resources for Payors

Presentations from 2015 Indiana Sickle Cell Conference
April 24, 2015

Russell Ware, MD, PhD
Hydroxyurea for Providers

The content of this video is the exclusive property of the presenting author. The unauthorized replication, use, or other distribution of this video or the content within it is strictly prohibited without the prior written consent of the author.

Kimber Blackwell, MPAS, PA-C
Sickle Cell Disease: Managing Acute & Chronic Complications in Adults

Did you like this? Share it: